Mammary NOS-type sarcoma with CD10 expression: A rare entity with features of myoepithelial differentiation

American Journal of Surgical Pathology

Volumn 30, Issue 4, 2006, Pages 450-456

  Leibl, Sebastian ^a   Moinfar, Farid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Breast; CD10; Immunoplastic carcinoma; Myoepithelial cells; Sarcoma

Indexed keywords

BIOLOGICAL MARKER; CALDESMON; CALPONIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; DESMIN; MASPIN; NITRIC OXIDE SYNTHASE; PROTEIN 14 3 3; PROTEIN P63; PROTEIN S 100; SMAD PROTEIN; STEROID RECEPTOR; VIMENTIN; MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST SARCOMA; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYSTOSARCOMA PHYLLOIDES; FEMALE; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MYOEPITHELIUM CELL; PROTEIN EXPRESSION; RARE DISEASE; BREAST TUMOR; CARCINOSARCOMA; CELL TRANSFORMATION; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; MYOEPITHELIOMA; PATHOLOGY; SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOSARCOMA; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOEPITHELIOMA; NEPRILYSIN; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 33646672173     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200604000-00004     Document Type: Article

References (28)

1. Adem C, Reynolds C, Ingle JN, et al. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 2004;91:237-241.
2. Blanchard DK, Reynolds CA, Grant CS, et al. Primary nonphylloides breast sarcomas. Am J Surg. 2003;186:359-361.
3. Burga AM, Tavassoli FA. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior. Am J Surg Pathol. 2003;27:343-348.
4. Callery CD, Rosen PP, Kinne DW. Sarcoma of the breast: a study of 32 patients with reappraisal of classification and therapy. Ann Surg. 1985;201:527-532.
5. Ceballos KM, Nielsen GP, Selig MK, et al. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am J Clin Pathol. 2000;114:746-753.
6. Christensen L, Schiodt T, Blichert-Toft M, et al. Sarcomas of the breast: a clinico-pathological study of 67 patients with long term follow-up. Eur J Surg Oncol. 1988;14:241-247.
7. Chu PG, Arber DA, Weiss LM, et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001;14:465-471.
8. Ciatto S, Bonardi R, Cataliotti L, et al. Sarcomas of the breast: a multicenter series of 70 cases. Neoplasma. 1992;39:375-379.
9. Dunne B, Lee AHS, Pinder SE, et al. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol. 2003;34:1009-1015.
10. Evans HL, Shipley J. Leiomyosarcoma. In: Fletcher CDM, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002:131-134.
11. Fletcher CDM, van den Berg E, Molenaar WM. Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In: Fletcher CDM, Unni K, Mertens F, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002:120-122.
12. Hefny AF, Bashir MO, Joshi S, et al. Stromal sarcoma of the breast: a case report. Asian J Surg. 2004;27:339-341.
13. Kalekou H, Kostopoulos I, Milias S, et al. Comparative study of CD34, alpha-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma. Histopathology. 2005;47:74-81.
14. Leibl S, Gogg-Kammerer M, Sommersacher A, et al. Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol. 2005;29:347-353.
15. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol. 2005;58:700-704.
16. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 2001;39:273-278.
17. McGowan TS, Cummings BJ, O'Sullivan B, et al. An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys. 2000;46:383-390.
18. Moore T, Lee AH. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology. 2001;38:62-67.
19. Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol. 2002;15:397-405.
20. Pandey M, Mathew A, Abraham EK, et al. Primary sarcoma of the breast. J Surg Oncol. 2004;87:121-125.
21. Pollard SG, Marks PV, Temple LN, et al. Breast sarcoma: a clinicopathologic review of 25 cases. Cancer. 1990;66:941-944.
22. Popnikolov NK, Ayala AG, Graves K, et al. Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas. Am J Clin Pathol. 2003;120:161-167.
23. Reis-Filho JS, Milanezi F, Paredes J, et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Morphol. 2003;11:1-8.
24. Rosen PP. Rosen's Breast Pathology, 2nd ed. Baltimore: Lippincott Williams & Wilkins, 2001:813-814.
25. Silverman JS, Tamsen A. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages. Histopathology. 1996;29:411-419.
26. Terrier P, Terrier-Lacombe MJ, Mouriesse H, et al. Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat. 1989;13:39-48.
27. Watanabe K, Kusakabe T, Hoshi N, et al. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum Pathol. 1999;30:392-396.
28. Zhu XQ, Shi YF, Cheng XD, et al. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol. 2004;92:71-79.